Literature DB >> 10976854

Comparison of self-reported and physician-reported antidepressant medication use.

M Cotterchio1, N Kreiger, G Darlington, A Steingart.   

Abstract

PURPOSE: Self-reported medication histories obtained in pharmacoepidemiologic case-control studies are subject to non-differential misclassification and to recall bias. The accuracy of self-reported antidepressant medication use has never been evaluated, but it is important in light of the hypothesis that antidepressant medications may be associated with cancer risk.
METHODS: Within a case-control study of several cancer sites, we compared self-reported antidepressant medication use with antidepressant use recorded in physicians' records. All female cases (n = 147) and controls (n = 119) who reported antidepressant medication use, and a 10% random sample (n = 114) of those who reported no antidepressant use, were asked to provide consent to contact, and the name(s) of their physician(s). These physicians completed a data abstraction form including information on antidepressant prescriptions recorded in patients' medical records.
RESULTS: Substantial agreement was found between subject- and physician-reported antidepressant medication use (kappa = 0.60 [95% confidence interval (CI), 0.47-0.74]; agreement = 80%), and use of specific antidepressant medications (agreement ranged from 82 to 100%), while moderate agreement was observed for duration of use (weighted kappa = 0.56 (95% CI, 0.32-0.79)), and date of first use [weighted kappa = 0.48 (95% CI, 0.23-0.72)]. The level of agreement did not differ markedly between cases and controls, except for duration of use, where agreement was somewhat greater for cases.
CONCLUSIONS: The similar level of agreement among cases and controls suggests that differential misclassification (e.g., recall bias) is unlikely in the reporting of most aspects of antidepressant medication use by women. Furthermore, the overall accurate self-reporting of antidepressant use suggests that there should be minimal non-differential antidepressant exposure misclassification.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10976854     DOI: 10.1016/s1047-2797(98)00072-6

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  11 in total

1.  Agreement between self-reported and pharmacy data on medication use in the Northern Finland 1966 Birth Cohort.

Authors:  Marianne Haapea; Jouko Miettunen; Sari Lindeman; Matti Joukamaa; Hannu Koponen
Journal:  Int J Methods Psychiatr Res       Date:  2010-06       Impact factor: 4.035

2.  Validity of Self-Reported Medication Use Compared With Pharmacy Records in a Cohort of Older Women: Findings From the Women's Health Initiative.

Authors:  Rebecca L Drieling; Andrea Z LaCroix; Shirley A A Beresford; Denise M Boudreau; Charles Kooperberg; Susan R Heckbert
Journal:  Am J Epidemiol       Date:  2016-07-07       Impact factor: 4.897

3.  Predictors of recall certainty of dates of analgesic medication use in pregnancy.

Authors:  Rose G Radin; Allen A Mitchell; Martha M Werler
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-06-04       Impact factor: 2.890

4.  Validation of self-reported history of colorectal cancer screening.

Authors:  Shariq Khoja; S Elizabeth McGregor; Robert J Hilsden
Journal:  Can Fam Physician       Date:  2007-07       Impact factor: 3.275

5.  The validity of a questionnaire on medicines used in health care practice: comparison of a questionnaire and computerized medical record survey.

Authors:  Ahmad Al-Windi
Journal:  Eur J Clin Pharmacol       Date:  2003-07-04       Impact factor: 2.953

6.  A comparison of self-reported analgesic use and detection of urinary ibuprofen and acetaminophen metabolites by means of metabonomics: the INTERMAP Study.

Authors:  Ruey Leng Loo; Queenie Chan; Ian J Brown; Claire E Robertson; Jeremiah Stamler; Jeremy K Nicholson; Elaine Holmes; Paul Elliott
Journal:  Am J Epidemiol       Date:  2012-01-05       Impact factor: 4.897

7.  Self-reported medication use validated through record linkage to national prescribing data.

Authors:  Jonathan D Hafferty; Archie I Campbell; Lauren B Navrady; Mark J Adams; Donald MacIntyre; Stephen M Lawrie; Kristin Nicodemus; David J Porteous; Andrew M McIntosh
Journal:  J Clin Epidemiol       Date:  2017-10-31       Impact factor: 7.407

8.  Validation of self-reported medication use for hypertension, diabetes, and dyslipidemia among employees of large-sized companies in Japan.

Authors:  Kota Fukai; Tomohisa Nagata; Koji Mori; Makoto Ohtani; Kenji Fujimoto; Masako Nagata; Yoshihisa Fujino
Journal:  J Occup Health       Date:  2020-01       Impact factor: 2.708

9.  The relationship between self-reported and registry-based data on use of psychoactive medications in postmenopausal women.

Authors:  Päivi H Rauma; Heli Koivumaa-Honkanen; Heikki Kröger; Marjo T Tuppurainen; Jussi Kauhanen; Risto J Honkanen
Journal:  BMC Psychiatry       Date:  2013-07-02       Impact factor: 3.630

10.  Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards.

Authors:  Karlijn J Joling; Maud Ten Koppel; Hein P J van Hout; Bregje D Onwuteaka-Philipsen; Anneke L Francke; Robert A Verheij; Jos W R Twisk; Rob J van Marum
Journal:  Int J Geriatr Psychiatry       Date:  2020-10-16       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.